Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Network meta-analyses of systemic treatments for psoriasis: a critical appraisal: Original Articles: Jabbar-Lopez ZK, Yiu ZZN, Ward V et al. Quantitative evaluation of biologic therapy options for psoriasis: a systematic review and network meta-analysis. J Invest Dermatol 2017; 137:1646-54. Sbidian E, Chaimani A, Garcia-Doval I et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev 2017; 12:CD011535.
Ellis AG, Flohr C, Drucker AM. Ellis AG, et al. Among authors: drucker am. Br J Dermatol. 2019 Feb;180(2):282-288. doi: 10.1111/bjd.17335. Epub 2018 Dec 21. Br J Dermatol. 2019. PMID: 30347448
Is baricitinib up next for atopic dermatitis?
Drucker AM. Drucker AM. Br J Dermatol. 2020 Aug;183(2):199-200. doi: 10.1111/bjd.19226. Epub 2020 Jul 13. Br J Dermatol. 2020. PMID: 32657421 No abstract available.
Atopic dermatitis and bone health: a systematic review.
Mukovozov IM, Morra DE, Giustini D, Tadrous M, Cheung AM, Drucker AM. Mukovozov IM, et al. Among authors: drucker am. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):615-628. doi: 10.1111/jdv.16895. Epub 2020 Oct 12. J Eur Acad Dermatol Venereol. 2021. PMID: 32853421
Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes.
Reynolds KA, Schlessinger DI, Yanes AF, Godinez-Puig V, Chen BR, Kurta AO, Cotseones JK, Chiren SG, Iyengar S, Ibrahim SA, Kang BY, Worley B, Behshad R, DeHoratius DM, Denes P, Drucker AM, Dzubow LM, Etzkorn JR, Harwood CA, Kim JYS, Lawrence N, Lee EH, Lissner GS, Marghoob AA, Guminiski A, Matin RN, Mattox AR, Mittal BB, Thomas JR, Zhou XA, Zloty D, Hughes BGM, Nottage MK, Green AC, Testori AAE, Argenziano G, Longo C, Zalaudek I, Lebbe C, Malvehy J, Saiag P, Cernea SS, Schmitt J, Kirkham JJ, Poon E, Sobanko JF, Cartee TV, Maher IA, Alam M. Reynolds KA, et al. Among authors: drucker am. Br J Dermatol. 2021 Jun;184(6):1113-1122. doi: 10.1111/bjd.19693. Epub 2021 Jan 11. Br J Dermatol. 2021. PMID: 33236347
168 results